Maze Therapeutics (MAZE) Current Assets (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Current Assets data on file, last reported at $379.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 26.72% year-over-year to $379.8 million; the trailing twelve-month figure through Mar 2026 stood at $379.8 million (up 26.72% YoY), and the FY2025 full-year result was $349.7 million, up 73.41% from the prior year.
• Current Assets advanced to $379.8 million in Q1 2026, from $349.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $391.3 million in Q3 2025 to a low of $201.7 million in Q4 2024.
• A 3-year average of $315.6 million and a median of $324.7 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 73.41% in 2025 and rose 26.72% in 2026, its largest moves.
• Tracing MAZE's Current Assets over 3 years: stood at $201.7 million in 2024, then soared by 73.41% to $349.7 million in 2025, then climbed by 8.6% to $379.8 million in 2026.
• Business Quant data shows MAZE's Current Assets at $379.8 million in Q1 2026, $349.7 million in Q4 2025, and $391.3 million in Q3 2025.